MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
13.19
+0.07 (0.53%)
Aug 21, 2026, 12:25 PM EDT - Market open
MediWound Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 11.86 | 16.96 | 20.22 | 18.69 | 26.5 | 23.76 | |
Revenue Growth | -40.26% | -16.14% | 8.22% | -29.48% | 11.50% | 9.19% |
Cost of Revenue | 10.03 | 13.71 | 17.59 | 15.11 | 13.33 | 14.99 |
Gross Profit | 1.83 | 3.25 | 2.63 | 3.58 | 13.17 | 8.77 |
Selling, General & Admin | 15.02 | 14.21 | 13.14 | 11.61 | 10.65 | 9.74 |
Research & Development | 19.03 | 14.32 | 8.88 | 7.47 | 10.18 | 10.26 |
Other Operating Expenses | -0.46 | -0.01 | 0.02 | - | - | - |
Operating Expenses | 33.6 | 28.52 | 22.03 | 19.08 | 20.83 | 19.99 |
Operating Income | -31.76 | -25.27 | -19.4 | -15.5 | -7.66 | -11.22 |
Interest Expense | - | -0.63 | -0.53 | -0.27 | -0.1 | -0.12 |
Interest & Investment Income | 11.4 | 1.86 | 2.05 | 2.34 | 0.27 | 0.01 |
Currency Exchange Gain (Loss) | -1.42 | -1.42 | -0.02 | -0.65 | 0.06 | -0.51 |
Other Non Operating Income (Expenses) | 1.74 | 1.74 | -12.26 | 7.35 | -11.4 | -0.19 |
EBT Excluding Unusual Items | -20.04 | -23.71 | -30.16 | -6.74 | -18.84 | -12.03 |
Other Unusual Items | - | - | - | 0.21 | -0.68 | -1.49 |
Pretax Income | -20.04 | -23.71 | -30.16 | -6.53 | -19.52 | -13.52 |
Income Tax Expense | 0.14 | 0.17 | 0.06 | 0.19 | 0.08 | 0.03 |
Earnings From Continuing Operations | -20.18 | -23.88 | -30.22 | -6.72 | -19.6 | -13.55 |
Net Income | -20.18 | -23.88 | -30.22 | -6.72 | -19.6 | -13.55 |
Net Income to Common | -20.18 | -23.88 | -30.22 | -6.72 | -19.6 | -13.55 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 12 | 11 | 10 | 9 | 5 | 4 |
Shares Outstanding (Diluted) | 12 | 11 | 10 | 9 | 5 | 4 |
Shares Change | 15.45% | 14.23% | 10.50% | 80.73% | 28.13% | 0.24% |
EPS (Basic) | -1.63 | -2.10 | -3.03 | -0.75 | -3.93 | -3.48 |
EPS (Diluted) | -2.25 | -2.10 | -3.03 | -0.75 | -3.93 | -3.48 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -28.53 | -21.63 | -19.9 | -16.93 | -12.44 | -9.41 |
Free Cash Flow Per Share | -2.30 | -1.90 | -2.00 | -1.88 | -2.49 | -2.42 |
Gross Margin | 15.46% | 19.19% | 13.03% | 19.15% | 49.69% | 36.91% |
Operating Margin | -267.75% | -148.98% | -95.94% | -82.95% | -28.91% | -47.22% |
Profit Margin | -170.10% | -140.80% | -149.46% | -35.94% | -73.97% | -57.03% |
Free Cash Flow Margin | -240.47% | -127.52% | -98.39% | -90.60% | -46.95% | -39.58% |
EBITDA | -30.75 | -24.28 | -18.65 | -14.2 | -6.39 | -9.98 |
EBITDA Margin | -259.20% | -143.17% | -92.20% | -75.98% | -24.11% | -42.01% |
D&A For EBITDA | 1.01 | 0.99 | 0.76 | 1.3 | 1.27 | 1.24 |
EBIT | -31.76 | -25.27 | -19.4 | -15.5 | -7.66 | -11.22 |
EBIT Margin | -267.75% | -148.98% | -95.94% | -82.95% | -28.91% | -47.22% |
Revenue as Reported | 11.86 | 16.96 | 20.22 | 18.69 | 26.5 | 23.76 |